['schizophrenia']
['dsp-5423p placebo', 'dsp-5423p 40mg', 'dsp-5423p 80mg', 'dsp-5423p placebo-to-flex', 'dsp-5423p active-to-flex']

        Inclusion Criteria:

          -  Patients who have schizophrenia diagnosed by DSM-5, diagnostic criteria

          -  Patients who are aged 18 years or older at informed consent

          -  Patient understands the objectives and procedures of the study and who provide written
             voluntarily consent to participate in the study, etc.

        Exclusion Criteria:

          -  Patients who fall under a contraindication listed in the blonanserin (LONASEN) package
             insert

          -  Patients with Parkinson disease

          -  Patients who previously received blonanserin, etc.
      